Optical Preclinical Imaging Market Analysis By Reagent (Bioluminescent Imaging Reagents, Fluorescent Imaging Reagents), By Application (Research & Development, Drug Discovery), By End User (Pharma & Biotech Companies, Research Institutes)
As per a new industry analysis by Fact.MR, a market research and competitive intelligence provider, the global optical preclinical imaging market is valued at US$ 612 million in 2023. Global sales of optical preclinical imaging devices are predicted to increase at a CAGR of 6.5% from 2023 to 2033.
In animal studies for the development of drugs, optical preclinical imaging technologies are employed. Monitoring the therapy response for early signs of efficacy also involves optical preclinical imaging. In-vivo imaging technology advancements give researchers a chance to quantitatively examine disease at the molecular level. With the use of in-vivo imaging, preclinical studies on animal models may be quickly and directly applied to clinical research in humans. This bridges the gap between in-vitro exploratory and in-vivo clinical research. In-vivo preclinical imaging is mostly used to treat diseases related to cancer, autoimmune disorders, neurological conditions, and cardiovascular problems.
The introduction of several fresh and technologically sophisticated medical equipment, medical imaging devices, and pharmaceutical & biopharmaceutical goods shows that the healthcare business is growing healthily, despite the extreme political and economic uncertainties happening across the world. Preclinical imaging and new variations of in-vivo preclinical imaging have been developed to evaluate new methods for revealing disease genesis, disease progression, and metastasis & progression of cancers.
Download a Free Sample Copy of this Report - https://www.factmr.com/connectus/sample?flag=S&rep_id=8379
North America currently dominates the global market due to the presence of well-established pharma and biotech industries. With the existence of the most prominent research facilities and medicine manufacturing sector, demand for optical preclinical imaging devices is increasing rapidly in Europe.
Key Takeaways from Market Study
“Rising prevalence of chronic disorders & infectious diseases across the world are boosting the demand for optical preclinical imaging solutions,” says a Fact.MR analyst.
Key Segments of Optical Preclinical Imaging Industry Research
Get Customization on this Report for Specific Research Solutions - https://www.factmr.com/connectus/sample?flag=RC&rep_id=8379
Key Market Developments
Key Companies Profiled
More Valuable Insights on Offer
Fact.MR, in its new offering, presents an unbiased analysis of the global optical preclinical imaging market, presenting historical demand data (2018 to 2022) and forecast statistics for the period of 2023 to 2033.
The study divulges essential insights into the market on the basis of modality (bioluminescence/fluorescence imaging systems, standalone fluorescence imaging systems, optical + X-ray/optical + CT), reagent (bioluminescent imaging reagents, fluorescent imaging reagents), application (research & development, drug discovery), and end user (pharma & biotech companies, research institutes), across five major regions of the world (North America, Europe, Asia Pacific, Latin America, and MEA).
Fact.MR is a market research and consulting agency with deep expertise in emerging market intelligence. Spanning a wide range - from automotive & industry 4.0 to healthcare, technology, chemical and materials, to even the most niche categories.
Optical Preclinical Imaging Market , Optical Preclinical Imaging Market Size , Optical Preclinical Imaging Market Share
Jun 29, 2023